FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129563195> ?p ?o ?g. }

• W2129563195 endingPage "223" @default.
• W2129563195 startingPage "215" @default.
• W2129563195 abstract "This study was undertaken to assess the effect of pioglitazone hydrochloride and rosiglitazone maleate on blood lipid levels and glycemic control when these drugs are used as adjunctive therapy in type 2 diabetes.Patients with type 2 diabetes receiving metformin and/or sulfonylurea (n = 829) were evaluated in this national, multicenter, retrospective study. Medical records from 318 endocrinology practices in the USA were randomly selected and screened for study inclusion. Data related to patient demographics and laboratory data were extracted from medical records and analyzed for primary and secondary outcomes.The primary study outcome was the mean change in plasma rosiglitazone was associated with no significant triglyceride (TG) levels. Secondary outcome measures included mean changes in total cholesterol (TChol), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) concentrations and hemoglobin A1C levels.With pioglitazone, TG levels declined by a mean of 51.5 mg/dl (P < 0.001), HDL-C levels rose by 3.3mg/dl (P < 0.001), and no change was seen in LDL-C or TChol. Treatment with change in TG levels and a 1.5mg/dl mean increase in HDL-C (P < 0.001). Furthermore, rosiglitazone therapy was associated with an 8 mg/dl mean increase in TChol (P < 0.001), and a 5.8 mg/dl mean increase in LDL-C (P < 0.001). Hemoglobin A1C levels were significantly reduced by approximately 1% within thiazolidinedione (TZD) cohorts (P < 0.001), but were not significantly different between study groups (P = 0.257).Results from this study suggest that pioglitazone has a more favorable effect on lipid profiles of patients with type 2 diabetes compared with rosiglitazone. In particular, differences were observed in TG and LDL-C levels. Both TZDs were equivalent at reducing hemoglobin A1C levels. These differences in lipid effects may have an impact on cardiovascular outcomes. The full clinical importance of these lipid alterations must be further assessed in prospective trials." @default.
• W2129563195 created "2016-06-24" @default.
• W2129563195 creator A5013350892 @default.
• W2129563195 creator A5040182038 @default.
• W2129563195 creator A5061781795 @default.
• W2129563195 creator A5065972153 @default.
• W2129563195 creator A5072090061 @default.
• W2129563195 creator A5081984589 @default.
• W2129563195 date "2004-01-01" @default.
• W2129563195 modified "2023-10-05" @default.
• W2129563195 title "Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes" @default.
• W2129563195 cites W169689332 @default.
• W2129563195 cites W1963886325 @default.
• W2129563195 cites W1985401361 @default.
• W2129563195 cites W2014759828 @default.
• W2129563195 cites W2014877159 @default.
• W2129563195 cites W2023447984 @default.
• W2129563195 cites W2080846100 @default.
• W2129563195 cites W2094083143 @default.
• W2129563195 cites W2097457805 @default.
• W2129563195 cites W2100514340 @default.
• W2129563195 cites W2108886453 @default.
• W2129563195 cites W2109934064 @default.
• W2129563195 cites W2110641080 @default.
• W2129563195 cites W2129805758 @default.
• W2129563195 cites W2131669718 @default.
• W2129563195 cites W2139634859 @default.
• W2129563195 cites W2154909966 @default.
• W2129563195 cites W2162181742 @default.
• W2129563195 cites W2182460401 @default.
• W2129563195 cites W2319983832 @default.
• W2129563195 cites W2400712338 @default.
• W2129563195 cites W2616141209 @default.
• W2129563195 cites W2975364463 @default.
• W2129563195 cites W38523360 @default.
• W2129563195 cites W424467158 @default.
• W2129563195 doi "https://doi.org/10.1185/030079903125002937" @default.
• W2129563195 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15006017" @default.
• W2129563195 hasPublicationYear "2004" @default.
• W2129563195 type Work @default.
• W2129563195 sameAs 2129563195 @default.
• W2129563195 citedByCount "42" @default.
• W2129563195 countsByYear W21295631952012 @default.
• W2129563195 countsByYear W21295631952013 @default.
• W2129563195 countsByYear W21295631952014 @default.
• W2129563195 countsByYear W21295631952015 @default.
• W2129563195 countsByYear W21295631952016 @default.
• W2129563195 countsByYear W21295631952017 @default.
• W2129563195 countsByYear W21295631952018 @default.
• W2129563195 countsByYear W21295631952023 @default.
• W2129563195 crossrefType "journal-article" @default.
• W2129563195 hasAuthorship W2129563195A5013350892 @default.
• W2129563195 hasAuthorship W2129563195A5040182038 @default.
• W2129563195 hasAuthorship W2129563195A5061781795 @default.
• W2129563195 hasAuthorship W2129563195A5065972153 @default.
• W2129563195 hasAuthorship W2129563195A5072090061 @default.
• W2129563195 hasAuthorship W2129563195A5081984589 @default.
• W2129563195 hasConcept C126322002 @default.
• W2129563195 hasConcept C134018914 @default.
• W2129563195 hasConcept C2776923340 @default.
• W2129563195 hasConcept C2777180221 @default.
• W2129563195 hasConcept C2777538456 @default.
• W2129563195 hasConcept C2778163477 @default.
• W2129563195 hasConcept C2778384471 @default.
• W2129563195 hasConcept C2778913445 @default.
• W2129563195 hasConcept C2779306644 @default.
• W2129563195 hasConcept C2780152017 @default.
• W2129563195 hasConcept C2780323712 @default.
• W2129563195 hasConcept C2780473172 @default.
• W2129563195 hasConcept C555293320 @default.
• W2129563195 hasConcept C71924100 @default.
• W2129563195 hasConcept C90924648 @default.
• W2129563195 hasConceptScore W2129563195C126322002 @default.
• W2129563195 hasConceptScore W2129563195C134018914 @default.
• W2129563195 hasConceptScore W2129563195C2776923340 @default.
• W2129563195 hasConceptScore W2129563195C2777180221 @default.
• W2129563195 hasConceptScore W2129563195C2777538456 @default.
• W2129563195 hasConceptScore W2129563195C2778163477 @default.
• W2129563195 hasConceptScore W2129563195C2778384471 @default.
• W2129563195 hasConceptScore W2129563195C2778913445 @default.
• W2129563195 hasConceptScore W2129563195C2779306644 @default.
• W2129563195 hasConceptScore W2129563195C2780152017 @default.
• W2129563195 hasConceptScore W2129563195C2780323712 @default.
• W2129563195 hasConceptScore W2129563195C2780473172 @default.
• W2129563195 hasConceptScore W2129563195C555293320 @default.
• W2129563195 hasConceptScore W2129563195C71924100 @default.
• W2129563195 hasConceptScore W2129563195C90924648 @default.
• W2129563195 hasIssue "2" @default.
• W2129563195 hasLocation W21295631951 @default.
• W2129563195 hasLocation W21295631952 @default.
• W2129563195 hasOpenAccess W2129563195 @default.
• W2129563195 hasPrimaryLocation W21295631951 @default.
• W2129563195 hasRelatedWork W1551046670 @default.
• W2129563195 hasRelatedWork W1964594176 @default.
• W2129563195 hasRelatedWork W2020625666 @default.
• W2129563195 hasRelatedWork W2028316975 @default.
• W2129563195 hasRelatedWork W2110102664 @default.
• W2129563195 hasRelatedWork W2120086542 @default.

• next